| GDCRNATools: an R/Bioconductor package for integrative analysis of lncRNA, miRNA and mRNA data in GDC R Li, H Qu, S Wang, J Wei, L Zhang, R Ma, J Lu, J Zhu, WD Zhong, Z Jia Bioinformatics 34 (14), 2515-2517, 2018 | 181 | 2018 |
| MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer Z Lin, G Chen, Y Zhang, H He, Y Liang, J Ye, Y Liang, R Mo, J Lu, Y Zhuo, ... Molecular cancer 16, 1-14, 2017 | 92 | 2017 |
| An eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer S Wang, W Su, C Zhong, T Yang, W Chen, G Chen, Z Liu, K Wu, W Zhong, ... Frontiers in Cell and Developmental Biology 8, 599494, 2020 | 82 | 2020 |
| Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis W Zhong, K Wu, Z Long, X Zhou, C Zhong, S Wang, H Lai, Y Guo, D Lv, ... Microbiome 10 (1), 94, 2022 | 66 | 2022 |
| E2F1 promotes tumor cell invasion and migration through regulating CD147 in prostate cancer YX Liang, JM Lu, RJ Mo, HC He, J Xie, FN Jiang, ZY Lin, YR Chen, ... International journal of oncology 48 (4), 1650-1658, 2016 | 58 | 2016 |
| Characterization of the m6A-associated tumor immune microenvironment in prostate cancer to aid immunotherapy Z Liu, J Zhong, J Zeng, X Duan, J Lu, X Sun, Q Liu, Y Liang, Z Lin, ... Frontiers in Immunology 12, 735170, 2021 | 41 | 2021 |
| Overexpression of PDZ-binding kinase confers malignant phenotype in prostate cancer via the regulation of E2F1 JH Chen, YX Liang, HC He, JY Chen, JM Lu, G Chen, ZY Lin, X Fu, ... International journal of biological macromolecules 81, 615-623, 2015 | 36 | 2015 |
| A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism R Liu, Y Feng, Y Deng, Z Zou, J Ye, Z Cai, X Zhu, Y Liang, J Lu, H Zhang, ... Journal of Experimental & Clinical Cancer Research 40 (1), 188, 2021 | 34 | 2021 |
| Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation MY Jiang, ZD Han, W Li, F Yue, J Ye, B Li, Z Cai, JM Lu, W Dong, X Jiang, ... Oncotarget 8 (46), 80295, 2017 | 30 | 2017 |
| Autophagy induced by overexpression of DCTPP1 promotes tumor progression and predicts poor clinical outcome in prostate cancer J Lu, W Dong, H He, Z Han, YJ Zhuo, RJ Mo, Y Liang, JG Zhu, R Li, H Qu, ... International journal of biological macromolecules 118, 599-609, 2018 | 29 | 2018 |
| HnRNP-L-regulated circCSPP1/miR-520h/EGR1 axis modulates autophagy and promotes progression in prostate cancer J Lu, C Zhong, J Luo, F Shu, D Lv, Z Liu, X Tan, S Wang, K Wu, T Yang, ... Molecular Therapy-Nucleic Acids 26, 927-944, 2021 | 24 | 2021 |
| 5-Methylcytosine RNA methyltransferases-related long non-coding RNA to develop and validate biochemical recurrence signature in prostate cancer K Wang, W Zhong, Z Long, Y Guo, C Zhong, T Yang, S Wang, H Lai, J Lu, ... Frontiers in molecular biosciences 8, 775304, 2021 | 23 | 2021 |
| Autophagy-related circRNA evaluation reveals hsa_circ_0001747 as a potential favorable prognostic factor for biochemical recurrence in patients with prostate cancer C Zhong, K Wu, S Wang, Z Long, T Yang, W Zhong, X Tan, Z Wang, C Li, ... Cell Death & Disease 12 (8), 726, 2021 | 23 | 2021 |
| Decreased HoxD10 expression promotes a proliferative and aggressive phenotype in prostate cancer RJ Mo, JM Lu, YP Wan, W Hua, YX Liang, YJ Zhuo, QW Kuang, YL Liu, ... Current Molecular Medicine 17 (1), 70-78, 2017 | 23 | 2017 |
| Immune-related biomarker risk score predicts prognosis in prostate cancer Z Liu, J Zhong, C Cai, J Lu, W Wu, G Zeng Aging (Albany NY) 12 (22), 22776, 2020 | 18 | 2020 |
| miR‑505 suppresses prostate cancer progression by targeting NRCAM Corrigendum in/10.3892/or. 2020.7696 XH Ling, H Fu, ZY Chen, JM Lu, YJ Zhuo, JH Chen, WD Zhong, Z Jia Oncology reports 42 (3), 991-1004, 2019 | 18 | 2019 |
| ARNT‐dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer G Chen, Z Cai, Z Lin, C Wang, Y Liang, Z Han, H He, R Mo, J Lu, B Pan, ... Molecular Carcinogenesis 59 (8), 897-907, 2020 | 16 | 2020 |
| Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer YX Liang, RJ Mo, HC He, JH Chen, J Zou, ZD Han, JM Lu, C Cai, ... Oncology Reports 33 (5), 2648-2654, 2015 | 16 | 2015 |
| Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer R Li, S Wang, Y Cui, H Qu, JM Chater, L Zhang, J Wei, M Wang, Y Xu, ... Briefings in Bioinformatics 22 (3), bbaa197, 2021 | 15 | 2021 |
| M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy C Zhong, Z Long, T Yang, S Wang, W Zhong, F Hu, JYC Teoh, J Lu, ... International Journal of Biological Sciences 19 (5), 1543, 2023 | 14 | 2023 |
Chuanfan ZhongUrologist, Zhujiang Hospital, Southern Medical University在 i.smu.edu.cn 的电子邮件经过验证
Chuanfan ZhongUrologist, Zhujiang Hospital, Southern Medical University在 i.smu.edu.cn 的电子邮件经过验证
Ruidong LiSenior Bioinformatics Scientist @ Gilead Sciences, Inc.在 gilead.com 的电子邮件经过验证